Jiangsu Tianji Pharmaceutical

Jiangsu Tianji Pharmaceutical is a specialized pharmaceutical manufacturer based in Nanjing, China, and operates as a key subsidiary of Grand Pharma (China Grand Pharmaceutical and Healthcare Holdings). The company is a leading global supplier of adrenergic active pharmaceutical ingredients (APIs) and finished injectable products, including epinephrine, norepinephrine, and isoprenaline. Its facilities are GMP-certified, supporting the production of critical care and emergency medicines used in treating life-threatening conditions such as cardiac arrest, anaphylaxis, and severe hypotension. Jiangsu Tianji Pharmaceutical plays a vital role in the global supply chain for essential medicines, serving both domestic Chinese markets and international exports. The company focuses on high-quality chemical synthesis and pharmaceutical formulation to maintain its position as a core production base for emergency medications.